Philips Launches Interventional Configuration To Assist In Stroke Assessment

June 4, 2010

Philips Allura Xper interventional X-ray system designed to visualize vessel structure beyond a clot and help physicians identify and assess the size and extent of an ischemic stroke.

Andover, Mass., USA – Today Royal Philips Electronics (NYSE: PHG, AEX: PHI) introduced Philips VasoCT, an intra-vascular interventional configuration for the Philips Allura Xper interventional X-ray system designed to visualize vessel structure beyond a clot and help physicians identify and assess the size and extent of an ischemic stroke. This ensures angiography suite treatment as quickly as possible, thus helping to improve outcomes and quality of life for the patient. VasoCT is based on a 3D rotational scan and a special injection protocol.

 

Stroke affects 15 million people worldwide each year, with five million people dying from strokes annually . It is the third leading cause of death in the U.S. and the number one reason for adult disability.  Thirty percent of those who have had a stroke need assistance walking, 26 percent become nursing home residents, and 19 percent have trouble speaking.

 

"Time is most essential when a stroke occurs.” said Bert van Meurs, senior vice president of Interventional X-ray for Philips Healthcare." VasoCT allows physicians a clear view on the location and size of the occlusion and surrounding cerebral blood vessels, which leads to assessment and implementation of treatment. VasoCT also visually aids physicians in navigating through the clot in the right direction.

 

Receiving quick medical attention significantly lowers the risk of disability and death. Through a rotational scan in the interventional neuro radiology suite, VasoCT reveals key information about cerebral vascular structures in detail.  It is one of the most comprehensive interventional imaging configurations in the Philips interventional X-ray suite, displaying the nuances and complexities beyond the actual occlusion and allowing for navigation in real time.

 

Professor Jacques Moret, M.D., a leading global authority on neuro interventional techniques said, "A stroke is a life-threatening condition that can get worse quickly unless the right diagnosis and treatment decisions are made in time. VasoCT provides physicians with the information needed to make important decisions at a crucial moment for the stroke patient."

 

VasoCT will be available in the near future as an interventional configuration to the Philips Allura Xper interventional neuro radiology suite. 

 


1. World Health Organization, The Atlas of Heart Disease and Stroke
2. Center for Disease Control,“Stroke Facts“

3. American Heart Foundation, Heart Disease and Stroke Statistics—2007 Update

For further information, please contact:

USA/Europe: Steve Kelly, Senior Public Relations Manager
Tel: +1 425-487-7479
E-mail: steve.kelly@philips.com

USA/Europe: Heidi Wilson, Senior Public Relations Manager
Tel: +1 978-659-7302
E-mail: heidi.wilson@philips.com

Asia Pacific: Kitty Kwan, Region Public Relations
Tel: +852 2821 5796
Email: kitty.kwan@philips.com.

About Royal Philips Electronics

Royal Philips Electronics of the Netherlands (NYSE: PHG, AEX: PHI) is one of the world's biggest electronics companies and Europe's largest, with sales of $37.66 Billion (EUR 30.3 billion) in 2004. With activities in the three interlocking domains of healthcare, lifestyle and technology and 160,900 employees in more than 60 countries, it has market leadership positions in medical diagnostic imaging and patient monitoring, color television sets, electric shavers, lighting and silicon system solutions. News from Philips is located at www.newscenter.philips.com/in_en.

 

View all News

.